Stoke Therapeutics
(NASDAQ) STOK
Stoke Therapeutics Financials at a Glance
Market Cap
$1.87B
Revenue (TTM)
$32.08M
Net Income (TTM)
-$169.77M
EPS (TTM)
-$2.84
P/E Ratio
-10.56
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Price
$30.00
Volume
28,834
Open
$30.40
Price
$30.00
Volume
28,834
Open
$30.40
Previous Close
$30.00
Daily Range
$29.31 - $30.40
52-Week Range
$11.17 - $40.22
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Price
$30.00
Volume
28,834
Open
$30.40
Previous Close
$30.00
Daily Range
$29.31 - $30.40
52-Week Range
$11.17 - $40.22
Estimated Earnings Date
Aug 10, 2026
STOK News
STOK: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Stoke Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
170
CEO
Ian Frederick Smith, CPA
Website
www.stoketherapeutics.comHeadquarters
Bedford, MA 01730, US
STOK Financials
Key Financial Metrics (TTM)
Gross Margin
90%
Operating Margin
-6%
Net Income Margin
-5%
Return on Equity
-46%
Return on Capital
-46%
Return on Assets
-38%
Earnings Yield
-9.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.87B
Shares Outstanding
62.28M
Volume
28.83K
Avg. Volume
636.53K
Financials (TTM)
Gross Profit
$184.42M
Operating Income
-$20.59M
EBITDA
-$5.12M
Operating Cash Flow
$45.59M
Capital Expenditure
-$670.00K
Free Cash Flow
$44.92M
Cash & ST Invst.
$284.67M
Total Debt
$3.01M
Stoke Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.23M
-96.1%
Gross Profit
$5.18M
-96.7%
Gross Margin
83.19%
N/A
Market Cap
$1.87B
N/A
Market Cap/Employee
$14.60M
N/A
Employees
128
N/A
Net Income
-$50.00M
-144.3%
EBITDA
-$45.56M
-139.7%
Quarterly Fundamentals
Total Cash
$343.55M
-3.9%
Total Debt
$3.42M
+45.6%
Accounts Receivable
$6.14M
+913.4%
Inventory
$0.00
N/A
Long Term Debt
$990.00K
N/A
Short Term Debt
$2.43M
+3.5%
Return on Assets
-38.30%
N/A
Return on Invested Capital
-46.03%
N/A
Free Cash Flow
-$60.94M
-146.3%
Operating Cash Flow
-$60.58M
-146.0%